TLR4 expression on monocyte subsets in myocardial infarction

Journal of Internal Medicine

Volumn 273, Issue 3, 2013, Pages 294-305

  Tapp, L D ^a   Shantsila, E ^a   Wrigley, B J ^a   Montoro Garcia, S ^a   Lip, G Y H ^a  

^a UNIVERSITY OF BIRMINGHAM   (United Kingdom)

Author keywords

Monocyte subsets; Myocardial infarction; Prognosis; Toll like receptor 4

Indexed keywords

CD14 ANTIGEN; CD16 ANTIGEN; CHEMOKINE RECEPTOR CCR2; INTERLEUKIN 6; TOLL LIKE RECEPTOR 4;

ADULT; ARTICLE; CELL COUNT; CLINICAL ARTICLE; CORONARY ARTERY DISEASE; FEMALE; FLOW CYTOMETRY; FOLLOW UP; HUMAN; MALE; MONOCYTE; NON ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; PRIORITY JOURNAL; PROTEIN EXPRESSION; ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; VENOUS BLOOD;

AGED; BIOLOGICAL MARKERS; CELL COUNT; FEMALE; FLOW CYTOMETRY; HUMANS; INTERLEUKIN-6; MALE; MIDDLE AGED; MYOCARDIAL CONTRACTION; MYOCARDIAL INFARCTION; NF-KAPPA B; PLATELET AGGREGATION; PROGNOSIS; TOLL-LIKE RECEPTOR 4;

EID: 84873993985     PISSN: 09546820     EISSN: 13652796     Source Type: Journal    
DOI: 10.1111/joim.12011     Document Type: Article

References (22)

1. Edfeldt K, Swedenborg J, Hansson GK, Yan ZQ. Expression of toll-like receptors in human atherosclerotic lesions: a possible pathway for plaque activation. Circulation 2002; 105: 1158-61.
2. Vabulas RM, Ahmad-Nejad P, Ghose S, Kirschning CJ, Issels RD, Wagner H. HSP70 as endogenous stimulus of the Toll/interleukin-1 receptor signal pathway. J Biol Chem 2002; 277: 15107-12.
3. Asehnoune K, Strassheim D, Mitra S, Kim JY, Abraham E. Involvement of reactive oxygen species in Toll-like receptor 4-dependent activation of NF-kappa B. J Immunol 2004; 172: 2522-9.
4. Xu XH, Shah PK, Faure E et al. Toll-like receptor-4 is expressed by macrophages in murine and human lipid-rich atherosclerotic plaques and upregulated by oxidized LDL. Circulation 2001; 104: 3103-8.
5. Ishikawa Y, Satoh M, Itoh T, Minami Y, Takahashi Y, Akamura M. Local expression of Toll-like receptor 4 at the site of ruptured plaques in patients with acute myocardial infarction. Clin Sci (Lond) 2008; 115: 133-40.
6. Nakamura M, Shimizu Y, Sato Y et al. Toll-like receptor 4 signal transduction inhibitor, M62812, suppresses endothelial cell and leukocyte activation and prevents lethal septic shock in mice. Eur J Pharmacol 2007; 569: 237-43.
7. Kashiwagi M, Imanishi T, Ozaki Y et al. Differential expression of Toll-like receptor 4 and human monocyte subsets in acute myocardial infarction. Atherosclerosis 2012; 221: 249-53.
8. Shantsila E, Wrigley B, Tapp L et al. Immunophenotypic characterization of human monocyte subsets: possible implications for cardiovascular disease pathophysiology. J Thromb Haemost 2011; 9: 1056-66.
9. Van de Werf F, Bax J, Betriu A et al. Management of acute myocardial infarction in patients presenting with persistent ST-segment elevation: the task force on the management of ST-segment elevation acute myocardial infarction of the European society of cardiology. Eur Heart J 2008; 29: 2909-45.
10. Ziegler-Heitbrock L, Ancuta P, Crowe S et al. Nomenclature of monocytes and dendritic cells in blood. Blood 2010; 116: e74-80.
11. Tapp LD, Shantsila E, Wrigley BJ, Pamukcu B, Lip GY. The CD14++CD16+ monocyte subset and monocyte-platelet interactions in patients with ST-elevation myocardial infarction. J Thromb Haemost 2012; 10: 1231-41.
12. Shantsila E, Montoro-Garcia S, Tapp LD, Apostolakis S, Wrigley BJ, Lip GYH. Fibrinolytic status in acute coronary syndromes: Evidence of differences in relation to clinical features and pathophysiological pathways. Thromb Haemost 2012; 108: 32-40.
13. Azeredo EL, Neves-Souza PC, Alvarenga AR et al. Differential regulation of toll-like receptor-2, toll-like receptor-4, CD16 and human leucocyte antigen-DR on peripheral blood monocytes during mild and severe dengue fever. Immunology 2010; 130: 202-16.
14. Xie P, Cao YS, Su P, Li YH, Gao ZL, Borst MM. Expression of toll-like receptor 4, tumor necrosis factor- alpha, matrix metalloproteinase-9 and effects of benazepril in patients with acute coronary syndromes. Clin Med Insights Cardiol 2010; 4: 89-93.
15. Methe H, Kim JO, Kofler S, Weis M, Nabauer M, Koglin J. Expansion of circulating Toll-like receptor 4-positive monocytes in patients with acute coronary syndrome. Circulation 2005; 111: 2654-61.
16. Satoh M, Shimoda Y, Maesawa C et al. Activated toll-like receptor 4 in monocytes is associated with heart failure after acute myocardial infarction. Int J Cardiol 2006; 109: 226-34.
17. Shantsila E, Lip GY. The role of monocytes in thrombotic disorders. Insights from tissue factor, monocyte-platelet aggregates and novel mechanisms. Thromb Haemost 2009; 102: 916-24.
18. Yonekawa K, Neidhart M, Altwegg LA et al. Myeloid related proteins activate toll-like receptor 4 in human acute coronary syndromes. Atherosclerosis 2011; 218: 486-92.
19. Sheu JJ, Chang LT, Chiang CH et al. Prognostic value of activated toll-like receptor-4 in monocytes following acute myocardial infarction. Int Heart J 2008; 49: 1-11.
20. Wyss CA, Neidhart M, Altwegg L et al. Cellular actors, toll-like receptors, and local cytokine profile in acute coronary syndromes. Eur Heart J 2010; 31: 1457-69.
21. Satoh M, Shimoda Y, Akatsu T, Ishikawa Y, Minami Y, Nakamura M. Elevated circulating levels of heat shock protein 70 are related to systemic inflammatory reaction through monocyte toll signal in patients with heart failure after acute myocardial infarction. Eur J Heart Fail 2006; 8: 810-5.
22. Shiraki R, Inoue N, Kobayashi S et al. Toll-like receptor 4 expressions on peripheral blood monocytes were enhanced in coronary artery disease even in patients with low C-reactive protein. Life Sci 2006; 80: 59-66.